.Attributes Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin led to improved progression-free and also total survival, bring about FDA approval as well as a brand new procedure choice for patients.